"Tivic hits enrolment target for vagus nerve stimulation trial" was originally created and published by Medical Device ...
Tivic Health Systems (Nasdaq:TIVC) announced today that it completed enrollment in a study for its vagus nerve stimulation (VNS) device.
The guidelines took years to finalize, but while regulators were drafting them, a new trend emerged: online pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback